Member Centre       Download

Subscribe

Follow us

Free newsletter sign up

Sign up to our free newsletter and get the latest 

news sent direct to your inbox

Etta Biotech Co., Ltd.  Copyright © 2014-2019 All Rights Reserved.   苏ICP备9051029号

  • F1

    F1

  • H1

    H1

  • HiDEN

    HiDEN

Recent Updates

View all

Milestone! Mettaforge Therapeutics, a joint venture company of Etta and Mayo, has been officially registered.
On July 3, 2019, US time, Mettaforge Therapeutics, a joint venture company initiated by Suzhou Etta Biotech Co., Ltd., Mayo Clinic and its team of scientists and doctors, was formally incorporated ...
The exhibition is over! Etta Flow Electroporator, strength to build brand!
Etta Biotech Invite You to Meet Shanghai ● bioLive China 2019
Good news! CE certificate for Etta X-Porator F1!

User Testimony

Dr. Li

PhD student, Shandong University

"22RV1 cell gene editing efficiency meets customer

requirements and homologous repair efficiency is

being optimized."

Sonanan

Department heads, Cyagen Biosciences

"Compared with previous electroporator, the

experimental cost is greatly reduced."

Dr. Hu

R&D Director, Genepharma

"Lower cost with stable results."

Some Demo Results

Product Display

Mr. Tan

Associate professor, SINANO of Chinese Academy of Sciences

X-Porator F1 with a maximum single treatment volume of up to 250ml.

293F,TE: 94.2%, V: 92.7%.

CHO-S,TE: 95.0%, V: 98.5%. 

"H1 leads to breakthrough in experiments. The results have been published in the Nano Research this year."

Read more>>

Read more>>

Read more>>